Jason Reeves

Director - Application Science Nucleai

Seminars

Tuesday 4th November 2025
Unlocking AI Spatial Biomarkers & Diagnostics for ADC Patient Selection
2:30 pm
  • Discussing how the MoA of ADCs and bispecifics warrant an AI-powered spatial biomarker approach for accurate patient selection
  • Outlining how novel, AI-powered spatial biomarkers are being deployed for clinical trial enrollment
  • Exploring how the exponential rise in ADC and bispecific trials and approvals will result in a new generation of diagnostics to aid physicians in treatment selection and what it means for drug developers
Jason Reeves- 16th World ADC San Diego